Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysis
Yi Li, Wei He
doi: https://doi.org/10.1101/2020.11.16.20232884
Yi Li
aSchool of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
Wei He
bShanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China
aSchool of Pharmacy, China Pharmaceutical University, Nanjing 210009, China

Article usage
Posted November 18, 2020.
Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysis
Yi Li, Wei He
medRxiv 2020.11.16.20232884; doi: https://doi.org/10.1101/2020.11.16.20232884
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)